APPLICATION
ANDA206697
TYPE
ANDA
ORIGINAL APPROVAL
2024-11-19
LATEST ACTION
2024-11-19
ROUTE
SUBCUTANEOUS
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription
Products
EXENATIDE SYNTHETICPrescription
EXENATIDE SYNTHETIC 300MCG/1.2ML (250MCG/ML) · INJECTABLE · SUBCUTANEOUS
EXENATIDE SYNTHETICPrescription
EXENATIDE SYNTHETIC 600MCG/2.4ML (250MCG/ML) · INJECTABLE · SUBCUTANEOUS
Approval history
2024-11-19UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.